My Quote Request
No products added yet
6505-01-115-3520
20 Products
NDC00182-1810-89
IBUPROFEN TABLETS,USP
NSN, MFG P/N
6505011153520
NSN
6505-01-115-3520
NDC00182-1810-89
IBUPROFEN TABLETS,USP
NSN, MFG P/N
6505011153520
NSN
6505-01-115-3520
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS IBUPROFEN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IBUPROFEN TABLETS USP 600MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
BRETHINE
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
BRETHINE
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
BRETHINE TABLETS
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
BRETHINE TABLETS
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00028-0072-90
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
NDC00028-0072-90
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505011153912
NSN
6505-01-115-3912
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DECA-DURABOLIN
NANDROLONE DECANOATE INJECTION,USP
NSN, MFG P/N
6505011155194
NSN
6505-01-115-5194
DECA-DURABOLIN
NANDROLONE DECANOATE INJECTION,USP
NSN, MFG P/N
6505011155194
NSN
6505-01-115-5194
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS NANDROLONE DECANOATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00052-0698-71
NANDROLONE DECANOATE INJECTION,USP
NSN, MFG P/N
6505011155194
NSN
6505-01-115-5194
NDC00052-0698-71
NANDROLONE DECANOATE INJECTION,USP
NSN, MFG P/N
6505011155194
NSN
6505-01-115-5194
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS NANDROLONE DECANOATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
DILAUDID
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
DILAUDID
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROMORPHONE HYDROCHLORIDE TABLETS USP 2MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: 100 TABLETS; REVERSE NUMBER PACK
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00054-8392-24
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
NDC00054-8392-24
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROMORPHONE HYDROCHLORIDE TABLETS USP 2MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: 100 TABLETS; REVERSE NUMBER PACK
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00074-2415-12
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
NDC00074-2415-12
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011155262
NSN
6505-01-115-5262
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROMORPHONE HYDROCHLORIDE TABLETS USP 2MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: 100 TABLETS; REVERSE NUMBER PACK
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
10600
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505011157563
NSN
6505-01-115-7563
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BUFFERED WITH ALUMINUM GLYCINATE 50 MG. AND MAGNESIUM CARBONATE 100 MG.
Related Searches:
NDC00182-1550-01
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505011157563
NSN
6505-01-115-7563
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BUFFERED WITH ALUMINUM GLYCINATE 50 MG. AND MAGNESIUM CARBONATE 100 MG.
Related Searches:
GRIFULVIN V
GRISEOFULVIN TABLETS,USP
NSN, MFG P/N
6505011157564
NSN
6505-01-115-7564
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MICRO-SIZE
Related Searches:
NDC00062-0211-60
GRISEOFULVIN TABLETS,USP
NSN, MFG P/N
6505011157564
NSN
6505-01-115-7564
NDC00062-0211-60
GRISEOFULVIN TABLETS,USP
NSN, MFG P/N
6505011157564
NSN
6505-01-115-7564
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MICRO-SIZE
Related Searches:
NDC00060-0135-65
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505011157566
NSN
6505-01-115-7566
NDC00060-0135-65
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505011157566
NSN
6505-01-115-7566
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 4.500 MILLIGRAMS OXYCODONE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.380 MILLIGRAMS OXYCODONE TEREPHTHALATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE II;
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
CERUMENEX
TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION
NSN, MFG P/N
6505011157836
NSN
6505-01-115-7836
CERUMENEX
TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION
NSN, MFG P/N
6505011157836
NSN
6505-01-115-7836
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, V/V TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE ACTIVE INGREDIENT
ADMINISTRATION: OTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION 10% 6ML
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH BLUNT END DROPPER
SPECIAL FEATURES: WITH SUITABLY WRAPPED BLUNT-END DROPPER; CONTAINS A SUITABLE PRESERVATIVE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00034-5490-06
TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION
NSN, MFG P/N
6505011157836
NSN
6505-01-115-7836
NDC00034-5490-06
TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION
NSN, MFG P/N
6505011157836
NSN
6505-01-115-7836
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, V/V TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE ACTIVE INGREDIENT
ADMINISTRATION: OTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIETHANOLAMINE POLYPEPTIDE OLEATE-CONDENSATE SOLUTION 10% 6ML
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH BLUNT END DROPPER
SPECIAL FEATURES: WITH SUITABLY WRAPPED BLUNT-END DROPPER; CONTAINS A SUITABLE PRESERVATIVE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00088-1555-90
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
NDC00088-1555-90
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS PAPAVERINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PAVABID
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
PAVABID
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS PAPAVERINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PAVABID CAPSULES
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
PAVABID CAPSULES
PAPAVERINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011157965
NSN
6505-01-115-7965
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS PAPAVERINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00409-1463-01
NALBUPHINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011159852
NSN
6505-01-115-9852
NDC00409-1463-01
NALBUPHINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011159852
NSN
6505-01-115-9852
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS NALBUPHINE HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NALBUPHINE HYDROCHLORIDE INJECTION 10MG/ML 1ML AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: SUBSTITUTE FOR PREFERRED NSN 6505-01-117-9690
TOTAL PRIMARY CONTAINER QUANTITY: 10
